Valproic AcId for Traumatic BRAin INjury Trial

Key facts

Sponsor

Northwestern University

Principal Investigator

Hasan Alam, MD

Northwestern University

Intervention

Valproic Acid (VPA)(drug)

Enrollment

432 target

Eligibility

18-65 years · All sexes

Timeline

2026 – 2030

Study locations (8)

• University of Alabama at Birmingham, Birmingham, Alabama, United States
• University of Arizona, Tucson, Arizona, United States
• University of Southern California, Los Angeles, California, United States
• University of California, Davis, Sacramento, California, United States
• Oregon Health & Science University, Portland, Oregon, United States
• Vanderbilt University Medical Center, Nashville, Tennessee, United States
• University of Texas Southwestern, Dallas, Texas, United States
• Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Collaborators

United States Department of Defense

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Moderate and severe traumatic brain injury

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE4NCT06866691
  Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide
  Wake Forest University Health Sciences
• RECRUITINGNANCT06241482
  Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care
  Shanghai 6th People's Hospital
• RECRUITINGPHASE1, PHASE2NCT06282965
  Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury
  University of Arizona
• RECRUITINGPHASE1NCT05716048
  Combinatory Rehabilitation Used for Substantially Helping Individuals With Traumatic Brain Injury
  Kessler Foundation
• ACTIVE NOT RECRUITINGNANCT05636020
  Intervention to Change Affect Recognition and Empathy
  Indiana University

See all trials for Moderate and severe traumatic brain injury →